As discussed above (SOX2 and Tumor-Initiating Cells/Cancer Stem Cells), this problem was avoided in those studies where GFP had been knocked into the endogenous SOX2 locus, and GFP+ cells were isolated and tested for enrichment of tumor-initiating/cancer stem cells. The gene discussed is SOX2; the disease is cancer.